Bayer’s supervisory board is due to discuss and vote in the next few days on a settlement of thousands of claims by plaintiffs that exposure to Roundup caused their cancer, a German business publication reported Tuesday. The settlement is expected to be worth $8 billion to $10 billion.
Citing sources, Handelsblatt reported that $2 billion of the total amount would be set aside for future claims.
A settlement has been in the works for some time, but the COVID-19 pandemic delayed negotiations over the last few months, the company had said. Bayer stock rose 4.8% in U.S. trading Tuesday.
For more news go to: www.Agri-Pulse.com